Physician

Alexander Z Sosenko, M.D.

According to 2025 Medicare claims, Alexander Sosenko, M.D. (NPI: 1851383780) practices pulmonary disease in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Will, IL. This provider's primary affiliated billing organization is MIDWEST RESPIRATORY, LTD. (NPI: 1407933831; TIN: 200207893) and primary practice location at 60435-8200. Sosenko is affiliated with the Essential Health Partners ACO, LLC (ACO ID: A4707), participating under the MSSP model.

Sosenko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 359 traditional Medicare patients, billed 1,026 HCPCS/CPT codes, and received $99,970 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,759 prescription claims across 238 beneficiaries totaling $448,422 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 818 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $201,702 to $99,970. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $64,866 and ending at $88,535.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	772	2,992	$201,702
2016	854	3,639	$249,447
2017	948	3,124	$246,362
2018	829	2,510	$206,964
2019	765	2,517	$195,326
2020	689	1,978	$178,799
2021	670	1,975	$178,824
2022	583	1,699	$147,067
2023	471	1,516	$139,592
2024	359	1,026	$99,970

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	313	2,044	$470,575
2016	332	2,169	$622,765
2017	325	2,166	$554,759
2018	293	1,962	$609,741
2019	330	2,047	$728,354
2020	279	1,838	$795,110
2021	269	1,837	$856,183
2022	238	1,719	$747,880
2023	259	1,731	$601,464
2024	238	1,759	$448,422

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	276	1,504	$74,021
2016	271	1,473	$71,507
2017	319	1,711	$81,716
2018	419	1,763	$117,263
2019	352	1,598	$90,637
2020	306	1,383	$53,724
2021	259	1,104	$59,465
2022	170	1,040	$262,377
2023	162	977	$94,925
2024	122	818	$82,369

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	89	199	$173
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	140	273	$95
94726	Test to determine lung volumes using sensors	61	61	$9
94060	Test to measure expiratory airflow and volume changes before and after medication administration	79	83	$8
94729	Test to examine how well the lungs exchange gases	60	60	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	156	7,320	$154,973
Breo Ellipta	Fluticasone/Vilanterol	148	5,400	$70,655
Spiriva Respimat	Tiotropium Bromide	61	2,166	$38,130
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	135	5,970	$25,907
Incruse Ellipta	Umeclidinium Bromide	57	2,130	$24,222

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	53	$53,812
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	22	159	$11,036
E1392	Portable oxygen concentrator, rental	Y	14	93	$3,043
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	12	43	$2,648
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	23	67	$1,630

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alexander Z. Sosenko, M.D.?

Tedicare shows public-source Medicare data for Alexander Z. Sosenko, M.D. (NPI 1851383780), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Z. Sosenko, M.D. have ACO affiliation data?

Alexander Z. Sosenko, M.D. is shown with ACO affiliation data for Essential Health Partners ACO, LLC (MSSP, ACO ID A4707).

What billing organization is linked to Alexander Z. Sosenko, M.D.?

Alexander Z. Sosenko, M.D. is linked to MIDWEST RESPIRATORY, LTD. (billing NPI 1407933831) in the available physician profile data.

Does Alexander Z. Sosenko, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.